FDA Clears Alzheimer’s Blood Test for Adults as Young as 40
The FDA has cleared the first blood-based Alzheimer’s test authorized for symptomatic adults as young as 40.
The FDA has cleared the first blood-based Alzheimer’s test authorized for symptomatic adults as young as 40.
Researchers identify molecular markers in saliva that could lead to new clinical tests for sleep loss.
Finding themselves in a vicious tug-of-war, clinical labs are struggling to keep pace with emerging designer drugs.
The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.
The approval expands the company's automated mass spectrometry menu to 39 tests.
The automated, PCR-free DNA library prep solution is designed for whole genome sequencing, targeting mid-throughput clinical and translational labs.